0001493152-22-034686.txt : 20221207
0001493152-22-034686.hdr.sgml : 20221207
20221207090143
ACCESSION NUMBER: 0001493152-22-034686
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221205
FILED AS OF DATE: 20221207
DATE AS OF CHANGE: 20221207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUFFOLO ROBERT R
CENTRAL INDEX KEY: 0001187308
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38630
FILM NUMBER: 221449233
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aridis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001614067
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320074500
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 983 UNIVERSITY AVENUE, BLDG. B
CITY: LOS GATOS
STATE: CA
ZIP: 95032
BUSINESS PHONE: (408) 385-1742
MAIL ADDRESS:
STREET 1: 983 UNIVERSITY AVENUE, BLDG. B
CITY: LOS GATOS
STATE: CA
ZIP: 95032
4
1
ownership.xml
X0306
4
2022-12-05
0
0001614067
Aridis Pharmaceuticals, Inc.
ARDS
0001187308
RUFFOLO ROBERT R
C/O ARIDIS PHARMACEUTICALS, INC.
983 UNIVERSITY AVE, BLDG. B
LOS GATOS,
CA
95032
1
0
0
0
Restricted Stock Units
2022-12-05
4
A
0
10000
0
A
Common Stock
10000
10000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
5,000 shares of Common Stock will vest on June 5, 2023 and 5,000 will vest on 12/5/2023.
/s/ Robert Ruffolo
2022-12-07